ASH Clinical Practice Guidelines on Diagnosis and Treatment of Amyloidosis
Over recent years, growing knowledge and advances in diagnostic approaches have enhanced the recognition of light chain (AL) amyloidosis. The purpose of these guidelines is to provide evidence-based recommendations to facilitate early and accurate diagnosis of AL amyloidosis. A second panel covering the treatment of AL amyloidosis will follow.
Amyloidosis is a rare group of disorders caused by protein misfolding. In North America, one of the common forms of amyloidosis is light chain amyloidosis (AL). These guidelines are intended to support patients, clinicians, and other health care professionals in their decisions about the diagn osis and treatment of AL.
Guideline Implementation Tools and Resources
Visual Summary
Concise visual aid to support understanding of the recommendations and to aid in clinical decision-making:
Pocket Guide
Brief, evidence-based pocket guides to help physicians provide quality care to patients.
Audit Report
A set of metrics to assess compliance with the ASH Clinical Practice Guidelines on Diagnosis of Light Chain Amyloidosis. Use this audit report to identify quality gaps at your institution and improve care for patients with light chain amyloidosis.